A detailed history of Impact Investors, Inc transactions in Incyte Corp stock. As of the latest transaction made, Impact Investors, Inc holds 3,068 shares of INCY stock, worth $250,379. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,068
Previous 8,351 63.26%
Holding current value
$250,379
Previous $506 Million 58.68%
% of portfolio
0.15%
Previous 0.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

SELL
$55.17 - $71.22 $291,463 - $376,255
-5,283 Reduced 63.26%
3,068 $209 Million
Q1 2025

Apr 25, 2025

SELL
$60.0 - $75.26 $3,420 - $4,289
-57 Reduced 0.68%
8,351 $506 Million
Q4 2024

Feb 04, 2025

BUY
$65.08 - $83.38 $547,192 - $701,059
8,408 New
8,408 $581 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Impact Investors, Inc Portfolio

Follow Impact Investors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impact Investors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Impact Investors, Inc with notifications on news.